| Original language | English |
|---|---|
| Article number | 209 |
| Pages (from-to) | 209 |
| Journal | Signal Transduction and Targeted Therapy |
| Volume | 6 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - 2 Jun 2021 |
Cite this
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver
}
In: Signal Transduction and Targeted Therapy, Vol. 6, No. 1, 209, 02.06.2021, p. 209.
Research output: Contribution to journal › Letter › peer-review
TY - JOUR
T1 - The natural analgesic conolidine targets the newly identified opioid scavenger ACKR3/CXCR7
AU - Szpakowska, Martyna
AU - Decker, Ann M.
AU - Meyrath, Max
AU - Palmer, Christie B.
AU - Blough, Bruce E.
AU - Namjoshi, Ojas A.
AU - Chevigné, Andy
N1 - Funding Information: This study was supported by the Luxembourg Institute of Health (LIH), Luxembourg National Research Fund (Pathfinder “LIH383”, INTER/FWO “Nanokine” grant 15/ 10358798, INTER/FNRS grants 20/15084569, PoC “Megakine” 19/14209621 and PRIDE 11012546 “NextImmune” and 14254520 “I2TRON”), F.R.S.-FNRS-Télévie (grants 7.4593.19, 7.4529.19, and 7.8504.20) and by RTI International Internal Research and Development Funds (awarded to O.N.). M.M. and C.P. are Luxembourg National Research Fund PhD fellows (grants AFR-3004509 and AFR-14616593). C.P. is of part of the Marie Skłodowska-Curie Innovative Training Networks ONCORNET2.0 “ONCOgenic Receptor Network of Excellence and Training” (MSCA-ITN-2020-ETN). We wish to thank Manuel Counson for technical assistance in binding competition experiments.
PY - 2021/6/2
Y1 - 2021/6/2
UR - http://www.scopus.com/inward/record.url?scp=85107397352&partnerID=8YFLogxK
UR - https://www.ncbi.nlm.nih.gov/pubmed/34075018
U2 - 10.1038/s41392-021-00548-w
DO - 10.1038/s41392-021-00548-w
M3 - Letter
C2 - 34075018
AN - SCOPUS:85107397352
SN - 2095-9907
VL - 6
SP - 209
JO - Signal Transduction and Targeted Therapy
JF - Signal Transduction and Targeted Therapy
IS - 1
M1 - 209
ER -